Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Urology Focus|October 28, 2017
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European SurveyKees Hendricksen, Atiqullah Aziz, Perrine Bes, et al.
Annals of Surgical Oncology|October 27, 2012
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomyEvanguelos Xylinas, Michael Rink, Giacomo Novara, et al.
Japanese Journal of Clinical Oncology|March 5, 2021
Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaborationNoriyoshi Miura, Keiichiro Mori, Ekaterina Laukhtina, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
European Urology|May 12, 2020
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus MeetingJeremy Yuen-Chun Teoh, Steven MacLennan, Vinson Wai-Shun Chan, et al.
European Urology|June 26, 2012
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomyShahrokh F Shariat, Michael Rink, Behfar Ehdaie, et al.
Nature Communications|June 9, 2021
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complexAntonín Brisuda, James C S Ho, Pancham S Kandiyal, et al.
European Urology Focus|April 2, 2025
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysisMarcin Miszczyk, Mateusz Bilski, Tamás Kói, et al.
Pageof 8